In parallel with the HNSCC-BP results, the DRGs from the SAS cell-injected mice demonstrated an increased expression of ERK1/2 phosphorylation, which is a molecular indicator of neuron excitation [14]. The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.